Obesity drug maker Versanis to be bought by Eli Lilly for $1.9 billionThe deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by demand for Novo Nordisk's Wegovy and Ozempic.[Collection]

The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by demand for Novo Nordisk's Wegovy and Ozempic.https://www.cnbc.com/2023/07/14/eli-lilly-to-acquire-obesity-drug-maker-versanis-for-1point9-billion.html